BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Owczarek D, Cibor D, Sałapa K, Głowacki MK, Mach T, Undas A. Reduced plasma fibrin clot permeability and susceptibility to lysis in patients with inflammatory bowel disease: a novel prothrombotic mechanism. Inflamm Bowel Dis 2013;19:2616-24. [PMID: 24108112 DOI: 10.1097/01.MIB.0000437041.59208.44] [Cited by in Crossref: 17] [Cited by in F6Publishing: 8] [Article Influence: 2.1] [Reference Citation Analysis]
Number Citing Articles
1 Undas A. Prothrombotic Fibrin Clot Phenotype in Patients with Deep Vein Thrombosis and Pulmonary Embolism: A New Risk Factor for Recurrence. Biomed Res Int 2017;2017:8196256. [PMID: 28740853 DOI: 10.1155/2017/8196256] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
2 Li Y, Ren JA, Wang GF, Gu GS, Wu XW, Liu S, Ren HJ, Hong ZW, Li JS. Impaired Coagulation Status in the Crohn's Disease Patients Complicated with Intestinal Fistula. Chin Med J (Engl) 2018;131:567-73. [PMID: 29483391 DOI: 10.4103/0366-6999.226072] [Reference Citation Analysis]
3 Bollen L, Vande Casteele N, Peeters M, Van Assche G, Ferrante M, Van Moerkercke W, Declerck P, Vermeire S, Gils A. The Occurrence of Thrombosis in Inflammatory Bowel Disease Is Reflected in the Clot Lysis Profile. Inflamm Bowel Dis 2015;21:2540-8. [PMID: 26313696 DOI: 10.1097/MIB.0000000000000531] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
4 Cibor D, Owczarek D, Butenas S, Salapa K, Mach T, Undas A. Levels and activities of von Willebrand factor and metalloproteinase with thrombospondin type-1 motif, number 13 in inflammatory bowel diseases. World J Gastroenterol 2017; 23(26): 4796-4805 [PMID: 28765701 DOI: 10.3748/wjg.v23.i26.4796] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
5 Zhang J, Guo Z, Yang W, Zhu Z, Kong W, Zheng S, Jiang L, Fei X, Chen Y, Liu J. D-Dimer levels are correlated with disease activity in Crohn's patients. Oncotarget 2017;8:63971-7. [PMID: 28969045 DOI: 10.18632/oncotarget.19250] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
6 Posch F, Hofer S, Thaler J, Hell L, Königsbrügge O, Grilz E, Mauracher LM, Gebhart J, Marosi C, Jilma B, Pabinger I, Ay C. Ex vivo properties of plasma clot formation and lysis in patients with cancer at risk for venous thromboembolism, arterial thrombosis, and death. Transl Res 2020;215:41-56. [PMID: 31525325 DOI: 10.1016/j.trsl.2019.08.009] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
7 Stadnicki A, Stadnicka I. Venous and arterial thromboembolism in patients with inflammatory bowel diseases. World J Gastroenterol 2021; 27(40): 6757-6774 [PMID: 34790006 DOI: 10.3748/wjg.v27.i40.6757] [Reference Citation Analysis]
8 Weisel JW, Litvinov RI. Visualizing thrombosis to improve thrombus resolution. Res Pract Thromb Haemost 2021;5:38-50. [PMID: 33537528 DOI: 10.1002/rth2.12469] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
9 Bazan-Socha S, Mastalerz L, Cybulska A, Zareba L, Kremers R, Zabczyk M, Pulka G, Iwaniec T, Hemker C, Undas A. Prothrombotic State in Asthma Is Related to Increased Levels of Inflammatory Cytokines, IL-6 and TNFα, in Peripheral Blood. Inflammation 2017;40:1225-35. [PMID: 28429138 DOI: 10.1007/s10753-017-0565-x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 3.3] [Reference Citation Analysis]